ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is a Good Night's Sleep at the Top of Your Wishlist?

Ashwagandha Helps Hormones - Aids Arthritis

Why You Should Be Eating More Porcini Mushrooms

A Breathalyzer for Disease?

How Bacopa Can Help Improve Your Cognitive Function

Magnesium Reduces Diabetes and Helps Keep You Young

Lavender Aromatherapy Can Ease Pre-Op Anxiety

Give Your Health a Much-Needed Boost With Geranium

The Role of Resveratrol in Achieving Optimal Health

Could Coconut Oil Help Reduce Antibiotics?

 
Print Page
Email Article

What Do We Know About Diagnosing AD?

  [ Not Yet Rated ]   [ Discuss This Article ]
By 1999 Progress Report by the NIA/NIH • www.ProHealth.com • December 13, 1999


Currently, clinicians use several tools to diagnose "possible AD" or "probable AD" in a patient who is having difficulties with memory or other mental functions. These tools include a patient history, physical exam, laboratory tests, brain scans, and a series of tests that measure memory, language skills, and other abilities related to brain functioning. However, in these patients, AD can be diagnosed conclusively only by examining the brain after death in an autopsy to determine the presence of characteristic plaques and tangles in certain brain regions.

The earlier an accurate diagnosis of AD is made, the greater the gain in managing symptoms and determining the natural history of AD. An early, accurate diagnosis of AD is especially important to patients and their families because it helps them plan for the future and pursue care options while the patient can still take part in making decisions.

Researchers have made significant progress in developing accurate diagnostic tests and techniques that can be used in living patients. In specialized research facilities, clinicians can now diagnose AD with up to 90 percent accuracy. For example, work is underway to develop new tests of mental status that might be used to distinguish between people who might have very early AD symptoms and those experiencing age-related normal memory loss. Other investigators have explored the utility of analyzing cerebrospinal fluid for levels of "sticky" beta-amyloid and tau for diagnosing AD. Researchers also have used positron emission tomography (PET) scans, an imaging method in living patients, to see whether they can detect changes in the way glucose is metabolized in parts of the brain that are most affected by AD. Another imaging method, known as single photon emission computed tomography (SPECT), also has been combined with genetic and psychological testing to predict which people with memory problems eventually will develop clinically diagnosed AD.

A particularly exciting area of work involves yet another imaging technique in the diagnosis of AD. This technique uses magnetic resonance imaging (MRI) to measure the size of various structures in the brain. Many studies have shown that AD causes some brain structures, particularly the hippocampus, to shrink early on in the disease, and scientists are exploring exactly how early this shrinkage, or atrophy, can be detected. Several teams of NIA-funded scientists have established the usefulness of MRI as a tool to help determine which people with memory problems are in the earliest stages of AD; to identify people who will later be diagnosed with AD; and to measure hippocampal volume to distinguish between people with mild cognitive impairment (MCI) and those with no memory or learning problems, and between people without AD and those with very mild AD.

Source:
National Institutes of Health
National Institute on Aging
1999 PROGRESS REPORT ON ALZHEIMER'S DISEASE



Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® Ultra EPA  - Fish Oil Energy NADH™ 12.5mg


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health
Research Links Green Tea to Weight Loss Research Links Green Tea to Weight Loss
Sleep Like a Baby in Nature's Cradle Sleep Like a Baby in Nature's Cradle
The Brain Boosting and Fatigue Fighting B-12 The Brain Boosting and Fatigue Fighting B-12
Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map